HIV infection: Treatment outcomes in older and younger adults

Journal of the American Geriatrics Society

Volumn 50, Issue 4, 2002, Pages 603-607

  Wellons, Melissa Fair ^a   Sanders, Linda ^b   Edwards, Lloyd J ^b   Bartlett, John A ^b   Heald, Alison E ^b   Schmader, Kenneth E ^b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Antiretroviral therapy; HIV; Immune system

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG TOLERABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; TREATMENT OUTCOME; VIRUS INHIBITION;

ADULT; AGE DISTRIBUTION; AGED; ANTI-HIV AGENTS; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME;

EID: 0036219743     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50152.x     Document Type: Article

References (17)

1. AIDS among persons aged > or = 50 years - United States, 1991-1996
2. Effect of age at seroconversion on the natural AIDS incubation distribution
3. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients
4. The importance of comorbidity in HIV-infected patients over 55: A retrospective case-control study
5. Characteristics of acquired immunodeficiency syndrome in older adults
6. Determinants of progression to AIDS in HIV-infected individuals: An update from the Italian Seroconversion Study
7. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population
8. HIV and aging as a model for immunosenescence
9. Infections in the elderly
10. Random-effects models for longitudinal data
11. Human immunodeficiency virus type 1 infection: Relationship of risk group and age to rate of progression to AIDS
12. Relationship between patient age and CD4+ lymphocyte repletion after successful virologic responses to highly-active anti-retroviral therapy
13. Comparison of antiretroviral treatment and outcomes of HIV patients ≥50 years of age with younger patients
14. Patient Characteristics and attitudes associated with antiretroviral (ar) adherence
15. Factors affecting adherence to antiretroviral therapy
16. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection